An announcement from BridgeBio Oncology Therapeutics ( (BBOT)) is now available. On January 7, 2026, BridgeBio Oncology Therapeutics reported positive preliminary clinical data across all three of its ...
A comprehensive, modular Python automation system for HEC-RAS flood analysis workflows. This professional-grade tool demonstrates advanced hydraulic modeling capabilities, Python integration, and ...
SOUTH SAN FRANCISCO - BridgeBio Oncology Therapeutics (NASDAQ:BBOT) announced Wednesday preliminary safety and efficacy data from three clinical-stage programs targeting RAS-pathway malignancies. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results